Live news , top stories, corporate news, company news, sector news, economy news, results analysis news, ceo interviews, fund manager interview, advisor interview, market news, bazaar talk, hot stocks news, ipo news, commodities news, mutual fund news, insurance news, news wire
20 July, 2018 06:54 IST
Cipla's arm receives final nod for generic Renvela tablets
Source: IRIS | 27 Oct, 2017, 10.00AM
Comments  |  Post Comment

Cipla's subsidiary, InvaGen Pharmaceuticals Inc., has received final approval for its Abbreviated New Drug Application (ANDA) for Sevelamer Carbonate Tablets, 800 mg, from the United States Food and Drug Administration (USFDA) to market a generic version of Genzyme’s Renvela Tablets, 800 mg.

Renvela Tablets had US sales of approximately USD 1.85 billion for the 12-month period ending August 2017, according to IMS Health. Sevelamer Carbonate Tablets, 800 mg is a AB-rated generic equivalent to the reference listed drug (RLD), Renvela Tablets, 800 mg of Genzyme Corporation and are indicated for the control of serum phosphorus in adults with chronic kidney disease (CKD) on dialysis.

Shares of the company gained Rs 10.1, or 1.65%, to trade at Rs 622.50. The total volume of shares traded was 130,385 at the BSE (9.48 a.m., Friday).



Cipla Limited   (Q,N,C,F)*

Comments Post comment 
 Post Comment
Name Email
Comment
Security Code type    into this box
Company Update
Yes Bank partners with 10 smart cities to tackle development challenges - 19-Jul-2018 17:36
Govt to infuse capital worth Rs 17.9 bn in Allahabad Bank - 19-Jul-2018 16:17
Trigyn Technologies wins contract from U.S. Army Picatinny Arsenal - 19-Jul-2018 16:11
Kotak Mahindra Bank quarterly net climbs 12.3% to Rs 10.25 bn - 19-Jul-2018 15:58
Bajaj Finance quarterly profit surges 83% - 19-Jul-2018 15:32
Tata Motors bags order to supply electric vehicles to Cognizant - 19-Jul-2018 13:19
Infosys Foundation signs accord with Bangalore Metro - 19-Jul-2018 11:49
Lupin receives tentative USFDA approval for generic Tadalafil tablets - 19-Jul-2018 11:34
Zydus Cadila gets USFDA's final nod for Piroxicam capsules - 19-Jul-2018 10:26
MCX takes preventive measures against technical glitches - 19-Jul-2018 10:19
Tata Power launches electric vehicle charging stations in Hyderabad - 18-Jul-2018 15:45
more...
Home  |   Shares  |   F&O  |   Mutual Funds  |   Loans  |   Insurance  |   News Centre
Wealth Tracker  |   Newsletters  |   Tax Corner  |   NRI Centre  |   Advertise
© All rights reserved. IRIS Business Services Limited
A Disclaimer